TANAKA Hiroshi 田中洋史

Researcher Number	80463991
Affiliation (based on the past Project Information) *help	2010: 新潟大学, 医歯学総合病院, 特任助教
Review Section/Research Field	Except Principal Investigator Respiratory organ internal medicine
Keywords	Except Principal Investigator 小細胞肺癌 / 制御性T細胞 / Th17 / その他 / 呼吸器感染症 / 肺線維症 / 非閉塞性肺疾患

Antitumor immunotherapy for small cell lung cancer with Th17 induction
- Principal Investigator
  
  KAGAMU Hiroshi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University

All 2010 2009 2008

All Journal Article Presentation

[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009
- Author(s)
  Hayashi, Y., H.Kuriyama, H.Umezu, J.Tanaka, T.Yoshimasu, T.Furukawa, H.Tanaka, H.Kagamu, F.Gejyo, H.Yoshizawa.
- Journal Title
  
  Intern Med 48
  
  Pages: 203-208
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Effect of ciclesonide on bronchial asthma in athletes.2009
- Author(s)
  Koya, T., T.Hasegawa, J.Tanaka, H.Kawakami, M.Hayashi, H.Kagamu, I.Narita, M.Arakawa, E.Suzuki.
- Journal Title
  
  J Asthma 46
  
  Pages: 1032-1036
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009
- Author(s)
  Yoshiki Hayashi, Hideyuki Kuriyama, Hiroshi Umezu, Junta Tanaka, T. Yoshimasu, T. Furukawa, Hiroshi Tanaka, Hiroshi Kagamu, Fumitake Gejyo, Hirohisa Yoshizawa.
- Journal Title
  
  Internal medicine 48
  
  Pages: 203-208
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.2008
- Author(s)
  Miura, S., H.Kagamu, H.Tanaka, H.Yoshizawa, F.Gejyo.
- Journal Title
  
  Scand J Immunol 67
  
  Pages: 385-391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Reciprocal CD4^+ T-cell balance of effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ regulatory T cells in small cell lung cancer reflects disease stage.2008
- Author(s)
  Koyama, K., H.Kagamu, S.Miura, T.Hiura, T.Miyabayashi, R.Itoh, H. Kuriyama, H.Tanaka, J.Tanaka, H.Yoshizawa, K. Nakata, F.Gejyo
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6770-6779
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Reciprocal CD4^+ T-Cell Balance of Effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage.2008
- Author(s)
  Kenichi Koyama, Hiroshi Kagamu, Satoru Miura, Toru Hiura, Takao Miyabayashi, Ryo Itoh, Hideyuki Kuriyama, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Fumitake Gejyo
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6770-6779
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity.2008
- Author(s)
  Satoru Miura, Hiroshi KagamuHiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Gejyo
- Journal Title
  
  Scandinavian journal of immunology. 67
  
  Pages: 385-391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity.2010
- Author(s)
  古塩純、各務博、市川紘将、馬場順子、宮林貴大、渡部聡、田中洋史、田中純太、吉澤弘久、中田光、成田一衛
- Organizer
  日本癌学会学術総会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo.2010
- Author(s)
  Takao Miyabayashi, Hiroshi Kagamu, Jun Koshio, Kosuke Ichikawa, Junko Baba, Satoshi Watanabe, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Ichiei Narita
- Organizer
  American Association for Cancer Research annual meeting
- Place of Presentation
  Washington DC
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Cancer stem cell targeted immunotherapy mediates potent antitumor reactivity against established parental melanoma.2009
- Author(s)
  宮林貴大、各務博、小山建一、馬場順子、渡部聡、田中純太、田中洋史、吉澤弘久、中田光、成田一衛
- Organizer
  日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜(intemational session)
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133^+ tumor-specific protein and induces antitumor immunity.2009
- Author(s)
  宮林貴大, 各務博, 小山建一, 栗山英之, 田中純太, 田中洋史, 吉澤弘久, 中田光, 下条文武
- Organizer
  ECCO 15-34^<th> ESMO Multidisciplinary Congress
- Place of Presentation
  Berlin
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Immunotherapy to eliminate cancer stem cells2008
- Author(s)
  宮林貴大、各務博、小山建一、太田毅、栗山英之、田中純太、田中洋史、吉澤弘久、下条文武
- Organizer
  日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(oral session)
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Immunotherapy to eliminate cancer stem cells(癌幹細胞根絶をめざした抗腫瘍免疫療法)2008
- Author(s)
  Takao Miyabayashi, Hiroshi Kagamu. Kenichi Koyama, Takeshi Ota, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Geiyo
- Organizer
  日本癌学会
- Place of Presentation
  パシフイコ横浜
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] 小細胞肺癌患者末梢血エフェクターCD4+T細胞/制御性T細胞バランスと病期、予後2008
- Author(s)
  小山建一, 各務博, 田中洋史, 栗山英之, 田中純太, 高田俊範, 吉滓弘久, 下条文武
- Organizer
  日本呼吸器学会
- Place of Presentation
  神戸コンベンションセンター
- Year and Date
  2008-06-17
- Data Source
  KAKENHI-PROJECT-20590915

1. KAGAMU Hiroshi (30418686)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
2. NAKATA Kou (80207802)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
3. YOSHIZAWA Hirohisa (50282984)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results

TANAKA Hiroshi 田中 洋史

Research Projects

Research Products

Co-Researchers

Antitumor immunotherapy for small cell lung cancer with Th17 induction

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Effect of ciclesonide on bronchial asthma in athletes.2009

Author(s)

Journal Title

Data Source

[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.2008

Author(s)

Journal Title

Data Source

[Journal Article] Reciprocal CD4^+ T-cell balance of effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ regulatory T cells in small cell lung cancer reflects disease stage.2008

Author(s)

Journal Title

Data Source

[Journal Article] Reciprocal CD4^+ T-Cell Balance of Effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage.2008

Author(s)

Journal Title

Data Source

[Journal Article] Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity.2008

Author(s)

Journal Title

Data Source

[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity.2010

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo.2010

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Cancer stem cell targeted immunotherapy mediates potent antitumor reactivity against established parental melanoma.2009

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133^+ tumor-specific protein and induces antitumor immunity.2009

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Immunotherapy to eliminate cancer stem cells2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Immunotherapy to eliminate cancer stem cells(癌幹細胞根絶をめざした抗腫瘍免疫療法)2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 小細胞肺癌患者末梢血エフェクターCD4+T細胞/制御性T細胞バランスと病期、予後2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

TANAKA Hiroshi 田中洋史